Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26020642 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Anna V Yudkina und 4 weiteren Autor:innen. Beteiligte Einrichtung: Siberian Branch of the Russian Academy of Sciences Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave., 630090 Novosibirsk, Ru…. Hauptthemen laut MEDLINE: DNA-Directed DNA Polymerase, Hydroxylamines, DNA Repair, DNA Adducts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Russian Ministry of Science and Education.
Abstract (Originalsprache)
The apurinic/apyrimidinic site (AP site) is a highly mutagenic and cytotoxic DNA lesion. Normally, AP sites are removed from DNA by base excision repair (BER). Methoxyamine (MOX), a BER inhibitor currently under clinical trials as a tumor sensitizer, forms adducts with AP sites (AP-MOX) resistant to the key BER enzyme, AP endonuclease. As AP-MOX remains unrepaired, translesion DNA synthesis is expected to be the main mechanism of cellular response to this lesion. However, the mutagenic potential of AP-MOX is still unclear. Here, we compare the blocking and mutagenic properties of AP-MOX and the natural AP site for major eukaryotic DNA polymerases involved in translesion synthesis: DNA polymerases η, ι, ζ, Rev1, and primase–polymerase PrimPol. The miscoding properties of both abasic lesions remained mostly the same for each studied enzyme. In contrast, the blocking properties of AP-MOX compared to the AP site were DNA polymerase specific. Pol η and PrimPol bypassed both lesions with the same efficiency. The bypass of AP-MOX by Pol ι was 15-fold lower than that of the AP site. On the contrary, Rev1 bypassed AP-MOX 5-fold better than the AP site. Together, our data suggest that Rev1 is best suited to support synthesis across AP-MOX in human cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Siberian Branch of the Russian Academy of Sciences Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave., 630090 Novosibirsk, Russia.
- Department of Natural Sciences, Novosibirsk State University, 2 Pirogova St., 630090 Novosibirsk, Russia.
- Institute of Gene Biology, Russian Academy of Sciences, 34/5 Vavilova St., 119334 Moscow, Russia.
ORCID-Profile: Anna A Novikova, Alena V Makarova, Dmitry O Zharkov
Förderung
- Russian Science Foundation
- Russian Ministry of Science and Education
Zitieren
APA
Yudkina, A. V., Novikova, A. A., Stolyarenko, A. D., Makarova, A. V., & Zharkov, D. O. (2025). Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020642
Vancouver
Yudkina AV, Novikova AA, Stolyarenko AD, Makarova AV, Zharkov DO. Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26020642
BibTeX
@article{Yudkina2025,
author = {Yudkina, Anna V and Novikova, Anna A and Stolyarenko, Anastasia D and Makarova, Alena V and Zharkov, Dmitry O},
title = {Bypass of Methoxyamine-Adducted Abasic Sites by Eukaryotic Translesion DNA Polymerases},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26020642}
}
EUVIMED